ZA200804734B - Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms - Google Patents
Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage formsInfo
- Publication number
- ZA200804734B ZA200804734B ZA200804734A ZA200804734A ZA200804734B ZA 200804734 B ZA200804734 B ZA 200804734B ZA 200804734 A ZA200804734 A ZA 200804734A ZA 200804734 A ZA200804734 A ZA 200804734A ZA 200804734 B ZA200804734 B ZA 200804734B
- Authority
- ZA
- South Africa
- Prior art keywords
- methods
- dosage forms
- sustained release
- oral dosage
- release oral
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73199505P | 2005-10-31 | 2005-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200804734B true ZA200804734B (en) | 2009-11-25 |
Family
ID=38069863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200804734A ZA200804734B (en) | 2005-10-31 | 2008-05-30 | Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN1957909B (en) |
ZA (1) | ZA200804734B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105287434A (en) * | 2009-03-18 | 2016-02-03 | 赢创罗姆有限公司 | Ethanol influence-resistant controlled-release medicine composition adopting coating containing neutral vinyl polymers and excipients |
CA2788659C (en) * | 2010-02-24 | 2015-05-05 | Pfizer Inc. | Veterinary compositions |
CN108309949B (en) * | 2018-03-15 | 2020-04-07 | 西南药业股份有限公司 | Preparation method of morphine osmotic pump tablet and product thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8626098D0 (en) * | 1986-10-31 | 1986-12-03 | Euro Celtique Sa | Controlled release hydromorphone composition |
US5266331A (en) * | 1991-11-27 | 1993-11-30 | Euroceltique, S.A. | Controlled release oxycodone compositions |
US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
ATE322892T1 (en) * | 1997-07-02 | 2006-04-15 | Euro Celtique Sa | STABILIZED SUSTAINED-RELEASE TRAMADOL FORMULATIONS |
PL341309A1 (en) * | 1997-12-22 | 2001-04-09 | Euro Celtique | Method of preventing overdosage of opioidic preparations |
-
2006
- 2006-09-18 CN CN 200610143171 patent/CN1957909B/en active Active
- 2006-10-31 CN CNA2006800495440A patent/CN101351202A/en active Pending
-
2008
- 2008-05-30 ZA ZA200804734A patent/ZA200804734B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1957909B (en) | 2013-09-11 |
CN1957909A (en) | 2007-05-09 |
CN101351202A (en) | 2009-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1106451A1 (en) | Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms | |
IL268462A (en) | Dosage forms of risedronate | |
IL182964A0 (en) | Gabapentin prodrug sustained release oral dosage forms | |
LT2046298T (en) | Pharmaceutical dosage form containing pharmaceutically acceptable solubilizing composition | |
ZA200810164B (en) | Sustained release pharmaceutical dosage form containing phenylphrine | |
IL194277A0 (en) | Solid oral dosage form containing an enhancer | |
EP2040731A4 (en) | Solid oral dosage form containing an enhancer | |
PL2077729T3 (en) | Probiotic oral dosage forms | |
IL193727A0 (en) | Dosage forms for administering combinations of drugs | |
EP1750674A4 (en) | Microparticles for oral delivery | |
PL2457563T3 (en) | Zero-order modified release solid dosage forms | |
IL188313A0 (en) | Highly bioavailable oral delayed release dosage forms of o-desmethylvenlafaxine succinate | |
PL1906961T3 (en) | Solid dosage formulations of fentanyl having improved buccal adsorption | |
ZA200706731B (en) | Dosage form and method for sustained release of a substituted pyrazine compound | |
IL177402A0 (en) | Composition for oral administration of tamsulosin hydrochloride | |
ZA200610770B (en) | Dosage form for delivery of multiple drug forms | |
IL179992A0 (en) | Immediate release formulations of memantine oral dosage forms | |
GB0616703D0 (en) | Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms | |
GB0612326D0 (en) | Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms | |
EP1765340A4 (en) | Sustained release composition for oral administration of niacin | |
ZA200804734B (en) | Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms | |
GB0403808D0 (en) | Films for use as dosage forms | |
EP1932923A4 (en) | Method for determination of effective dose of methotrexate | |
SE0602280L (en) | Procedures for reducing alcohol-induced dose dumping for delayed-release oral opioid dosage forms | |
IL202272A0 (en) | Process for forming solid oral dosage forms of angiotensin ii receptor antagonists |